Related Experiment Video
Updated: Feb 17, 2026
04:28
Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
Published on: March 23, 2016
13.3K
Orodispersible Films for Compounding Pharmacies
Anderson O Ferreira1, Marcos Antônio F Brandão2,3, Francisco José Raposo2
1BF-Fox Technologies, Matias Barbosa, MG, Brazil. bffoxtec@gmail.com.
International Journal of Pharmaceutical Compounding
|December 9, 2017
Summary
Orodispersible films offer rapid drug release in the mouth without water, making them ideal for emergencies and convenient for patients. This dosage form is gaining popularity and presents opportunities for compounding pharmacies.
Area of Science:
- Pharmaceutical Technology
- Drug Delivery Systems
Background:
- Orodispersible films are solid dosage forms designed for rapid dissolution in the oral cavity.
- They facilitate quick local or systemic release of active pharmaceutical ingredients.
- Their ease of use, without water or chewing, enhances patient compliance, especially in emergency situations or for individuals with swallowing difficulties.
Purpose of the Study:
- To explore the fundamental aspects of orodispersible films.
- To highlight their potential applications and preparations within compounding pharmacies globally.
Main Methods:
- Literature review on orodispersible film technology.
- Discussion of formulation considerations for compounding.
Main Results:
- Orodispersible films provide a versatile platform for drug delivery.
- The development of simpler technologies is making them more accessible for compounding.
Conclusions:
- Orodispersible films are a significant and evolving dosage form with growing consumer acceptance.
- They represent a promising area for innovation and practice in compounding pharmacies worldwide.
Related Concept Videos
01:27Drug Delivery Systems: Different Types
16
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
16
01:23Oral Drug Delivery Systems: Introduction
22
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
22
01:11Oral Drug Delivery Systems: Delayed-Release Systems
24
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
24
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
6
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
6
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
189
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
189
01:26Oral Drug Delivery Systems: Continuous-Release Systems
21
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
21